Invests in
Locations:
Min Investment:
$10,000.00Max Investment:
$100,000,000.00Target Investment:
$10,000,000.00
Education
Lists including Vineeta
Investments
Pomelo Care
Total Funding: $79M
Santa Ana Bio
Total Funding: $170M
Valar Labs
Total Funding: $26M
knownwell
Total Funding: $25M
Gate Bioscience
Total Funding: $60M
Waymark
Total Funding: $87M
Thyme Care
Total Funding: $140M
Amber Bio
Total Funding: $26M
Orbital Therapeutics
Total Funding: $270M
Function Oncology
Total Funding: $28M
Work Experience
2020
General Partner
2020
We invest in biotech and healthtech companies that are developing novel drugs, scaling products to transform disease treatment and prevention, and building the underlying AI + technology infrastructure we need to access better health. Board Director at several of our portfolio companies: Amber Bio, Arda Therapeutics, BigHat Biosciences, Gate Bioscience, GC Therapeutics, knownwell, Orbital Therapeutics, Rezo Therapeutics, Pearl Health, Pomelo Care, Thyme Care, and Waymark
Adjunct Clinical Assistant Professor
2020
I am a physician focused on cancer survivorship. My clinic is part of the Division of Primary Care and Population Health.
2024
Board Director
2024
Board Member
2021
2021
Committee Member
2021
Member of the Committee to Visit the Harvard Medical School and School of Dental Medicine.
2015 - 2019
Venture Partner
2015 - 2019
Board Director at Maze Therapeutics. Was privileged to lead diligence and support early stage investments in amazing teams including SQZ Biotech ($SQZ), Spero Therapeutics ($SPRO), Ideaya Biosciences ($IDYA), Foghorn Therapeutics ($FHTX), Locana Bio, Arrakis Therapeutics, Kindbody, and others. Evaluated investment opportunities and worked with portfolio companies across biotech, diagnostics, platform tools, and digital health.
2015 - 2018
Director, Product Management
2016 - 2018
Helped to build an oncology network and data platform of unprecedented scale. Led partnership with Foundation Medicine to link real-world clinical and genomic datasets.
Product Manager
2015 - 2016
2008 - 2015
MD/PhD
2008 - 2015
Studied genetic causes of common human diseases. Focus on population genetics, analysis and interpretation of next-generation sequencing data, and clinical translation.
2010 - 2012
Data Scientist
2010 - 2012
Kyruus is a big data start-up which provides patient access and referral management solutions to health systems.
2007 - 2008
Business Analyst
2007 - 2008
Operations, strategy, and M&A for large U.S. pharmaceutical, biotech, and medical device companies. Worked for an upcoming academic medical center in Dubai.